Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Diphenhydramine × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Hairy Cell 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vomiting 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Postoperative Nausea and Vomiting 1 Philadelphia Chromosome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 NSCLC 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Leukemia, B-Cell 1

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡